FDA hands Cassiopea its first approval, for acne drug Winlevi
pharmaphorum
AUGUST 28, 2020
An androgen receptor inhibitor, Winlevi (clascoterone) has been cleared by the US regulator for the treatment of acne in patients 12 years and older and is due to be launched early next year, according to the company. Retinoids can help unclog pores, while antibiotics can limit the growth of bacteria.
Let's personalize your content